Abstract
EIPL (extensive intra-operative peritoneal lavage) therapy was developed as a prophylactic strategy for peritoneal recurrence, with the goal of improving the quality of life and survival span for advanced gastric cancer patients with peritoneal free cancer cells. The purpose of this article is to review the therapys contribution to a remarkable improvement in the 5-year survival for patients with positive lavage cytology on prospective randomized controlled clinical trials. We also advocate for the adoption of the EIPL as the optimal treatment protocol for advanced gastric cancer.
Keywords: Clinical trial, EIPL, gastric cancer, intra-peritoneal free cancer cells, peritoneal recurrence, RT-PCR, survival, EIPL (extensive intra-operative peritoneal lavage), prophylactic strategy, intra-peritoneal chemotherapy (IPC), (EIPL-IPC) group, peritoneal metastasis, serosa-invasive tumors
Reviews on Recent Clinical Trials
Title: Adopting Extensive Intra-operative Peritoneal Lavage (EIPL) as the Standard Prophylactic Strategy for Peritoneal Recurrence
Volume: 6 Issue: 3
Author(s): Shinya Shimada, Masafumi Kuramoto, Takashi Marutsuka, Yasushi Yagi and Hideo Baba
Affiliation:
Keywords: Clinical trial, EIPL, gastric cancer, intra-peritoneal free cancer cells, peritoneal recurrence, RT-PCR, survival, EIPL (extensive intra-operative peritoneal lavage), prophylactic strategy, intra-peritoneal chemotherapy (IPC), (EIPL-IPC) group, peritoneal metastasis, serosa-invasive tumors
Abstract: EIPL (extensive intra-operative peritoneal lavage) therapy was developed as a prophylactic strategy for peritoneal recurrence, with the goal of improving the quality of life and survival span for advanced gastric cancer patients with peritoneal free cancer cells. The purpose of this article is to review the therapys contribution to a remarkable improvement in the 5-year survival for patients with positive lavage cytology on prospective randomized controlled clinical trials. We also advocate for the adoption of the EIPL as the optimal treatment protocol for advanced gastric cancer.
Export Options
About this article
Cite this article as:
Shimada Shinya, Kuramoto Masafumi, Marutsuka Takashi, Yagi Yasushi and Baba Hideo, Adopting Extensive Intra-operative Peritoneal Lavage (EIPL) as the Standard Prophylactic Strategy for Peritoneal Recurrence, Reviews on Recent Clinical Trials 2011; 6 (3) . https://dx.doi.org/10.2174/157488711796575603
DOI https://dx.doi.org/10.2174/157488711796575603 |
Print ISSN 1574-8871 |
Publisher Name Bentham Science Publisher |
Online ISSN 1876-1038 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Peptides Targeting Gap Junctional Structures
Current Pharmaceutical Design Anti-Angiogenesis and RGD-Containing Snake Venom Disintegrins
Current Pharmaceutical Design Evaluation of Anticonvulsants for Possible Use in Neuropathic Pain
Current Medicinal Chemistry The ErbB Receptors and their Ligands in Cancer: An Overview
Current Drug Targets Toxicity and Relative Biological Effectiveness of Alpha Emitting Radioimmunoconjugates
Current Radiopharmaceuticals Genetic Polymorphisms of Drug Metabolising Enzymes and Drug Transporters in Relation to Cancer Risk
Current Cancer Therapy Reviews Self-assembling Peptide Nanofibers Containing D-amino Acids for Tetrandrine Delivery
Current Signal Transduction Therapy Advancement in Microsphere Preparation Using Natural Polymers and Recent Patents
Recent Patents on Drug Delivery & Formulation [6]-gingerol as a Cancer Chemopreventive Agent: A Review of Its Activity on Different Steps of the Metastatic Process
Mini-Reviews in Medicinal Chemistry Synthesis, In Vitro Hydrolysis, Bioanalytical Method Development and Pharmacokinetic Study of an Amide Prodrug of Ibuprofen
Current Pharmaceutical Analysis Mitochondria as Possible Pharmaceutical Targets for the Effects of Vitamin E and its Homologues in Oxidative Stress-Related Diseases
Current Pharmaceutical Design Synthesis of Pyrido-annelated Diazepines, Oxazepines and Thiazepines
Current Medicinal Chemistry Mn-SOD and Chronic Inflammation of Gastric Mucosa
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry The Role of Survivin for Radiation Oncology: Moving Beyond Apoptosis Inhibition
Current Medicinal Chemistry Surface Antigens/Receptors for Targeted Cancer Treatment: The GnRH Receptor / Binding Site for Targeted Adenocarcinoma Therapy
Current Cancer Drug Targets Intracellular Signaling of the Aging Suppressor Protein Klotho
Current Molecular Medicine Prokinetic Agents and QT Prolongation: A Familiar Scene with New Actors
Current Drug Safety Research Advances in the Treatment of Melanoma by Treat Melanoma
Current Topics in Medicinal Chemistry Targeting Drugs to APJ Receptor: The Prospect of Treatment of Hypertension and Other Cardiovascular Diseases
Current Drug Targets The Clinical Application of Circulating Tumor Cells and DNAs as Prognostic and Predictive Biomarkers in Gastrointestinal Cancer
Current Cancer Drug Targets